Five medical organizations this week released a toolkit for clinicians in post-acute and long-term care settings about the benefits of the COVID-19 bivalent booster and oral antiviral therapeutics. 

“This fall we are facing the possibility of a so-called ‘tripledemic’ featuring COVID-19, RSV, and the flu,” said Christopher Laxton, executive director of AMDA – The Society for Post-Acute and Long-Term Care Medicine. “At the same time, we see new COVID variants increasing in prevalence and able to evade some of our key therapeutics. That means it’s more important than ever to make sure everyone is protected.”

AMDA developed the toolkit with the American Society of Consultant Pharmacists, American Association of Nurse Practitioners, American Academy of Physician Associates, and Gerontological Advanced Practice Nurses Association.

Related News Articles

Perspective
As Congress convenes for its post-election lame-duck session, we are turning up the pressure to secure additional support for hospitals and the patients and…
Headline
The Centers for Medicare & Medicaid Services today issued its calendar year 2023 final rule for the home health prospective payment system, which…
Headline
The Centers for Medicare & Medicaid Services yesterday released new FAQs to help state Medicaid and the Children’s Health Insurance Programs prepare…
Headline
In a study of 151 tax-exempt hospitals reported yesterday in JAMA Network Open, 84% updated their charity care policies between 2019 and 2021. Among the…
Headline
The U.S. Department of Health and Human Services on Monday awarded $25 million in planning grants to expand access to home and community-based services through…
Headline
The Centers for Medicare & Medicaid Services today issued an informational bulletin urging states to use existing Medicaid authority to drive better…